Literature DB >> 9406160

Changes in fatty acid compositions of myocardial lipids in rats with heart failure following myocardial infarction.

Y Nasa1, Y Sakamoto, A Sanbe, H Sasaki, F Yamaguchi, S Takeo.   

Abstract

Changes in fatty acid composition of myocardial lipids were examined in rats with heart failure following myocardial infarction. Left ventricular systolic pressure (LVSP) was decreased and left ventricular end-diastolic pressure (LVEDP) was elevated 24 h, 1 and 12 weeks after left coronary artery ligation (CAL), suggesting the development of heart failure at these periods in this model. Hearts were isolated 24 h, 1 week and 12 weeks after the operation. Myocardial lipids in the infarcted scar tissue, non-infarcted remaining left ventricle including interseptum and right ventricle were separated into phospholipid (PL), triacylglycerol (TG), diacylglycerol (DAG) and free fatty acid (FFA) fractions. In the scar tissue PL content markedly decreased whereas TG, DAG and FFA contents increased 24 h after CAL. Despite a marked decrease in constituted fatty acids of PL fraction in the scar tissue the percentage of arachidonic acid in PL was elevated 12 weeks after CAL, suggesting that release of arachidonic acid during PL degradation was suppressed. In the non-infarcted viable left ventricle PL content remained unchanged throughout the experiment whereas TG, DAG and FFA contents were elevated 24 h after CAL. Despite no changes in PL and other lipid contents in the non-infarcted tissue the percentage of linoleic acid in PL was reduced and that of docosahexaenoic acid in PL was elevated 12 weeks after CAL. Our findings showed that myocardial lipid composition of the non-infarcted left ventricle was altered only in an early stage of the development of heart failure and fatty acid compositions of PL was exchanged in a late stage of the development of heart failure. The exchange may be related to cardiac dysfunction or myocardial remodelling in the rat with heart failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406160

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury.

Authors:  K R Chien; J Abrams; A Serroni; J T Martin; J L Farber
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

2.  Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.

Authors:  Y Nasa; K Ichihara; Y Abiko
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

Review 3.  Rat infarct model of myocardial infarction and heart failure.

Authors:  S Goldman; T E Raya
Journal:  J Card Fail       Date:  1995-03       Impact factor: 5.712

4.  Decreased 1,2-diacylglycerol levels in myopathic hamster hearts during the development of heart failure.

Authors:  K Okumura; Y Yamada; J Kondo; H Hashimoto; T Ito; J Kitoh
Journal:  J Mol Cell Cardiol       Date:  1991-04       Impact factor: 5.000

5.  Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats.

Authors:  C I Johnston; V Mooser; Y Sun; B Fabris
Journal:  Clin Exp Pharmacol Physiol       Date:  1991-02       Impact factor: 2.557

6.  Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy.

Authors:  P Anversa; A V Loud; V Levicky; G Guideri
Journal:  Am J Physiol       Date:  1985-06

7.  Separation of neutral lipids and free fatty acids by high-performance liquid chromatography using low wavelength ultraviolet detection.

Authors:  J G Hamilton; K Comai
Journal:  J Lipid Res       Date:  1984-10       Impact factor: 5.922

8.  Differential changes in left and right ventricular SR calcium transport in congestive heart failure.

Authors:  N Afzal; N S Dhalla
Journal:  Am J Physiol       Date:  1992-03

9.  Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution.

Authors:  M C Fishbein; D Maclean; P R Maroko
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

10.  The concept of lipid domains in membranes.

Authors:  M J Karnovsky; A M Kleinfeld; R L Hoover; R D Klausner
Journal:  J Cell Biol       Date:  1982-07       Impact factor: 10.539

View more
  5 in total

1.  Hesperidin, a flavanone glycoside, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats.

Authors:  Palanisamy Selvaraj; Kodukkur Viswanathan Pugalendi
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

2.  Effects of long-term treatment with eicosapentaenoic acid on the heart subjected to ischemia/reperfusion and hypoxia/reoxygenation in rats.

Authors:  S Takeo; Y Nasa; K Tanonaka; K Yabe; M Nojiri; M Hayashi; H Sasaki; K Ida; K Yanai
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

3.  Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.

Authors:  Karen M O'Shea; Ramzi J Khairallah; Genevieve C Sparagna; Wenhong Xu; Peter A Hecker; Isabelle Robillard-Frayne; Christine Des Rosiers; Tibor Kristian; Robert C Murphy; Gary Fiskum; William C Stanley
Journal:  J Mol Cell Cardiol       Date:  2009-08-22       Impact factor: 5.000

4.  The role of calcium-independent phospholipase A2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heart.

Authors:  Derek K Zachman; Adam J Chicco; Sylvia A McCune; Robert C Murphy; Russell L Moore; Genevieve C Sparagna
Journal:  J Lipid Res       Date:  2009-09-09       Impact factor: 5.922

5.  Sex-specific cardiac cardiolipin remodelling after doxorubicin treatment.

Authors:  Maryline Moulin; Audrey Solgadi; Vladimir Veksler; Anne Garnier; Renée Ventura-Clapier; Pierre Chaminade
Journal:  Biol Sex Differ       Date:  2015-10-15       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.